Atea Pharmaceuticals, Inc. - Common Stock (AVIR)
CUSIP: 04683R106
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 78,888,889
- Total 13F shares
- 53,581,427
- Share change
- -1,653,062
- Total reported value
- $478,985,081
- Put/Call ratio
- 124%
- Price per share
- $8.94
- Number of holders
- 134
- Value change
- -$368,375,568
- Number of buys
- 83
- Number of sells
- 81
Quarterly Holders Quick Answers
What is CUSIP 04683R106?
CUSIP 04683R106 identifies AVIR - Atea Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04683R106:
Top shareholders of AVIR - Atea Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
16%
|
12,416,530
|
$435,324,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.9%
|
5,427,655
|
$190,294,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
5,179,955
|
$181,608,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
6.2%
|
4,928,756
|
$172,802,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.2%
|
4,136,801
|
$145,035,000 | — | 30 Sep 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
4.7%
|
3,700,000
|
$129,722,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.9%
|
2,259,224
|
$79,208,000 | — | 30 Sep 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.1%
|
1,655,087
|
$58,027,000 | — | 30 Sep 2021 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
2.1%
|
1,637,331
|
$57,405,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.9%
|
1,495,965
|
$52,449,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
1,102,852
|
$38,666,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,032,596
|
$36,202,000 | — | 30 Sep 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.95%
|
750,307
|
$26,306,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.9%
|
713,225
|
$25,006,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
591,361
|
$20,733,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.56%
|
442,677
|
$15,520,000 | — | 30 Sep 2021 | |
| BANQUE PICTET & CIE SA |
13F
|
Company |
0.56%
|
438,596
|
$15,377,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.54%
|
422,210
|
$14,803,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
393,179
|
$13,785,000 | — | 30 Sep 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.43%
|
339,553
|
$11,905,000 | — | 30 Sep 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.42%
|
332,200
|
$11,647,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
317,579
|
$11,134,000 | — | 30 Sep 2021 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
309,126
|
$10,838,000 | — | 30 Sep 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.38%
|
302,532
|
$10,607,000 | — | 30 Sep 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.36%
|
283,423
|
$9,937,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.36%
|
281,719
|
$9,877,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.34%
|
268,690
|
$9,420,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
259,269
|
$9,090,000 | — | 30 Sep 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
257,416
|
$9,025,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.23%
|
185,265
|
$6,495,000 | — | 30 Sep 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.23%
|
179,346
|
$6,288,000 | — | 30 Sep 2021 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.23%
|
178,555
|
$6,260,000 | — | 30 Sep 2021 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.22%
|
173,950
|
$6,099,000 | — | 30 Sep 2021 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
0.21%
|
167,701
|
$5,880,000 | — | 30 Sep 2021 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.21%
|
164,577
|
$5,770,000 | — | 30 Sep 2021 | |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT |
13F
|
Company |
0.21%
|
162,800
|
$5,708,000 | — | 30 Sep 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.19%
|
150,000
|
$5,259,000 | — | 30 Sep 2021 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.18%
|
141,520
|
$4,962,000 | — | 30 Sep 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.18%
|
142,514
|
$4,934,000 | — | 30 Sep 2021 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.17%
|
138,000
|
$4,838,000 | — | 30 Sep 2021 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.16%
|
123,877
|
$4,343,000 | — | 30 Sep 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.15%
|
117,600
|
$4,123,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
115,671
|
$4,055,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.14%
|
109,095
|
$3,825,000 | — | 30 Sep 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.14%
|
107,306
|
$3,762,000 | — | 30 Sep 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
104,378
|
$3,660,000 | — | 30 Sep 2021 | |
| CM Management, LLC |
13F
|
Company |
0.13%
|
100,000
|
$3,506,000 | — | 30 Sep 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.13%
|
100,000
|
$3,506,000 | — | 30 Sep 2021 | |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd |
13F
|
Company |
0.13%
|
100,000
|
$3,506,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.13%
|
99,482
|
$3,488,000 | — | 30 Sep 2021 |
Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock (AVIR) as of Q4 2021
As of 31 Dec 2021,
Atea Pharmaceuticals, Inc. - Common Stock (AVIR) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,581,427 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., EcoR1 Capital, LLC, Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, and VOLORIDGE INVESTMENT MANAGEMENT, LLC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
137
Q4 2021 holders
134
Holder diff
-3
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.